Nexteer Automotive Group Ltd (1316)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 21 Oct 2026
Key indicators
| Last close | HKD 4.260 |
|---|---|
| 52-week range | 3.650 – 7.968 |
| Return, 1 month / 3 months | −8.8% / +9.2% |
| Return, 1 year / 3 years | −42.0% / +1.7% |
| Trend | Below its 200-day average |
| RSI (14) | 36 |
| Volatility (1 year) | 49.0% |
| Worst drawdown (1 year) | -51.3% |
| Average daily value traded | 44.73M HKD |
| Dividend yield | 3.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nexteer Automotive Group designs and manufactures steering and driveline systems for the automotive industry. Its products include electric power steering, hydraulic steering, steering columns and halfshafts, supplied to car and light truck makers around the world. The company serves global vehicle manufacturers from operations in North America, Europe and Asia, and it is based in the United States with a corporate presence in Hong Kong. Its customers are mainly original equipment automakers rather than retail buyers.
On this site Nexteer Automotive Group Ltd appears as a stock on the Hong Kong Stock Exchange (Hong Kong), code 1316, with prices in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Nexteer Automotive Group Ltd (1316) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 4.260 on 21 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 1,158 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 42.0% and over the last three months it rose 9.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 41 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -18.4% | ||
| From 52-week high | -45.5% | ||
| Momentum | 51 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 9.2% | ||
| 6-month return | -17.2% | ||
| 12-month return, skipping the last month | -36.5% | ||
| Stability (higher is calmer) | 52 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 49.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -51.3% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 44.73M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.4% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Income: Dividend is small or irregular.
Returns
| 1 week | −3.9% |
|---|---|
| 1 month | −8.8% |
| 3 months | +9.2% |
| 6 months | −17.2% |
| 1 year | −42.0% |
| 3 years | +1.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 4.776 / 5.223 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.172 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Jun 2026 | HKD 0.1428 |
| 23 Jun 2025 | HKD 0.0680 |
| 21 Jun 2024 | HKD 0.0233 |
| 23 Jun 2023 | HKD 0.0366 |
| 23 Jun 2022 | HKD 0.0743 |
| 10 Jun 2021 | HKD 0.0727 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.